Article View: sci.med.pharmacy
Article #128Re: Rapid onset of action of Amineptine on depression
From: F. Frank LeFever
Date: Wed, 04 Aug 1999 00:00
Date: Wed, 04 Aug 1999 00:00
66 lines
3955 bytes
3955 bytes
Here I am, caught with my references down (again). I helped organize a conference for NYNG a few years ago, which included (among other things) a presentation of neuroimaging data which suggested that cognitive therapy (n.b.: I don't we can accept the simplistic equating of psychotherapy and "understanding"; v. infra) and pharmacotherapy (with a specific SSRI, I believe) produced similar changes in regional brain activation in those whose obsessive-compulsive disorder was alleviated. Sorry, cannot for the life of me think of the guy's name. From California, I think... Anyway, this is not so esoteric; fairly well-known finding, so you should be able to search it out (via Medline or whatever). I cite it just as another example (in addition to the one alluded to below) that there are as yet poorly explored and even less understood ways in which different therapies can not only result in similar outcomes behaviorally but may in some cases do so because of similar effects on the neuronal substrate of the disorder. This could provide a basis for independent (i.e. if monotherapy), or additive, or synergistic effects of different therapies. One caveat: I would not want to depend on cognitive therapy or any other non-physiological therapy for really severe depression. My impression (subject to correction, of course) is that studies showing comparable results for psychotherapy and pharmacotherapy do so with a different population: those with mild/moderate depression and/or those without "true" depression (e.g. with "reactive depression", "adjustment reaction", etc.). I almost wrote "pharmacotherapy or ECT" but realized it was not likely one would find enought subjects with mild/moderate depression undergoing ECT... More re regional differences in activation: we are all hoping for continued validation of TMS (transcranial magnetic stimulation), which not only offers the hope of less deleterious side effects than ECT, but in contrast to ECT's "sledge-hammer" or "shotgun" approach, only SLIGHTLY refined by the option of unilateral ECT (yes, yes, I know, seizure will spread to the other hemisphere, but it is applied unlaterally, and clearly has a unilateral bias in its immediate aftermath) offers the possibility of zeroing in more precisely on relevant brain SUB-regions--important both for understanding of the mechanisms of depression, and (we assume) for better treatments. F. Frank LeFever, Ph.D. New York Neuropsychology Group In <WFvp3.5039$B5.56894@news1.rdc1.bc.home.com> "Sodah" <sodah1@NO-SPAMhome.com> writes: > >It wouldn't hurt people to do a little research on the description of >_clinical_ depression, its nature and its modern treatment. For example, it >is fairly well established that clinically depressed patients respond better >to a combination of psychotherapy (i.e. "understanding") _plus_ >antidepressant drug therapy, than to either therapy alone. What you >fancifully refer to as 'chemical short circuiting', happens to be in >practice, 'what works' > >Sodah >
Technical Details
Message-ID:
<7o85ee$o4a@dfw-ixnews4.ix.netcom.com>Path:
arc1-ca.pugleaf.net!unknown!not-for-mailReferences:
<3796e8af.16349144@nn-tk004.ocn.ad.jp> <uBgxcaG1#GA.332@cpmsnbbsa05> <WFvp3.5039$B5.56894@news1.rdc1.bc.home.com>Show Full Headers
Complete Article Headers
X-Google-Language: ENGLISH,ASCII-7-bit X-Google-Thread: 10e572,5640e1a6d3ca5ed4 X-Google-Attributes: gid10e572,public X-Google-Thread: 13289b,5640e1a6d3ca5ed4 X-Google-Attributes: gid13289b,public X-Google-Thread: 1045ed,5640e1a6d3ca5ed4 X-Google-Attributes: gid1045ed,public X-Google-Thread: f4552,5640e1a6d3ca5ed4 X-Google-Attributes: gidf4552,public From: flefever@ix.netcom.com(F. Frank LeFever) Subject: Re: Rapid onset of action of Amineptine on depression Date: 1999/08/04 Message-ID: <7o85ee$o4a@dfw-ixnews4.ix.netcom.com> X-Deja-AN: 508599264 References: <3796e8af.16349144@nn-tk004.ocn.ad.jp> <uBgxcaG1#GA.332@cpmsnbbsa05> <WFvp3.5039$B5.56894@news1.rdc1.bc.home.com> Organization: Netcom X-NETCOM-Date: Tue Aug 03 8:36:14 PM CDT 1999 Newsgroups: sci.med.pharmacy,fr.bio.pharmacie,bionet.neuroscience,alt.support-depression